Back
ESC Premium Access

The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial

Session: ACS diagnosis and treatment
Topic: Thrombosis, Platelets, and Coagulation
Speaker: Professor C. Cannon (Boston, US)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)
38 presentations
0 follower

6 more presentations in this session

Long vs. short dual antiplatelet therapy in ACS patients treated with prasugrel or ticagrelor and coronary revascularization: a propensity score analysis from the RENAMI registry

Speaker: Doctor F. Fioravanti (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Exploring the value of the PRECISE-DAPT score after complex percutaneous coronary intervention to inform dual antiplatelet therapy duration decision-making.

Speaker: Doctor F. Costa (Messina, IT)

Access
Abstract
Slides
Like
Thumbnail

Diagnostic evaluation of a new high-sensitive point-of-care troponin I assay

Speaker: Doctor N. Soerensen (Hamburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Diagnostic accuracy of high sensitive cardiac troponin T in patients with suspected acute coronary syndrome and severe chronic kidney disease

Speaker: Doctor B. Alushi (Munich, DE)

Access
Abstract
Slides
Like
Thumbnail

Does complying guidelines matter?

Speaker: Doctor I. Campos (Braga, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

ACS diagnosis and treatment

Speakers: Professor C. Cannon, Doctor F. Fioravanti, Doctor F. Costa, Doctor N. Soerensen, Doctor B. Alushi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources